In 2025, a significant federal bill is making waves in the U.S. healthcare and pharmaceutical sectors. The proposed legislation aims to reclassify Ivermectin—a medication traditionally prescribed by doctors—as an over-the-counter (OTC) drug. This shift would mean Americans could buy Ivermectin USA more easily, without needing a prescription. Ivermectin, widely known for its antiparasitic properties, has […]